Stock Information
Prime Medicine Inc (PRME)
Ticker Symbol: PRME
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $566.93 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.2595
Revenue (TTM): $0.02 M
Dividend Yield: N/A%
ROE: -188.82%
Latest News
-
Prime Medicine Receives New Zealand's Regulator Clearance For Its Clinical Trial Application For PM577a To Treat Wilson Disease
Thu, Jun 18, 2026 8:08 AM
-
Prime Medicine's Prime Editing Is Worth The Risk
Sat, Jun 13, 2026 4:51 AM
Key Financials
Financial data not available
